Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × DOXO-EMCH × Clear all

NCT01706835 2022-02-10

Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors